BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 38548358)

  • 1. How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registry-based cohort study from Norway.
    Igland J; Forster R; Jenum AK; Strandberg RB; Berg TJ; Røssberg JI; Iversen MM; Buhl ES
    BMJ Open; 2024 Mar; 14(3):e077027. PubMed ID: 38548358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction Ability of Charlson, Elixhauser, and Rx-Risk Comorbidity Indices for Mortality in Patients with Hip Fracture. A Danish Population-Based Cohort Study from 2014 - 2018.
    Vesterager JD; Madsen M; Hjelholt TJ; Kristensen PK; Pedersen AB
    Clin Epidemiol; 2022; 14():275-287. PubMed ID: 35299726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 6 Mortality Risk Scores for Prediction of 1-Year Mortality Risk in Older Adults With Multimorbidity.
    Schneider C; Aubert CE; Del Giovane C; Donzé JD; Gastens V; Bauer DC; Blum MR; Dalleur O; Henrard S; Knol W; O'Mahony D; Curtin D; Lee SJ; Aujesky D; Rodondi N; Feller M
    JAMA Netw Open; 2022 Jul; 5(7):e2223911. PubMed ID: 35895059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.
    Hippisley-Cox J; Coupland C
    BMJ; 2017 Nov; 359():j5019. PubMed ID: 29158232
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessing Performance and Clinical Usefulness in Prediction Models With Survival Outcomes: Practical Guidance for Cox Proportional Hazards Models.
    McLernon DJ; Giardiello D; Van Calster B; Wynants L; van Geloven N; van Smeden M; Therneau T; Steyerberg EW;
    Ann Intern Med; 2023 Jan; 176(1):105-114. PubMed ID: 36571841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and validation of a morbidity index based on the International Classification of Primary Care.
    Sandvik H; Ruths S; Hunskaar S; Blinkenberg J; Hetlevik Ø
    Scand J Prim Health Care; 2022 Jun; 40(2):305-312. PubMed ID: 35822650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cohort profile: Outcomes & Multi-morbidity In Type 2 diabetes (OMIT) - a national registry-based observational cohort with focus on care and treatment of key high-risk groups in Norway.
    Forster RB; Strandberg RB; Bø Tibballs KL; Nøkleby K; Berg TJ; Iversen T; Hagen TP; Richardsen KR; Cooper J; Sandberg S; Løvaas KF; Nilsen RM; Iversen MM; Jenum AK; Buhl ESS
    BMJ Open; 2022 May; 12(5):e054840. PubMed ID: 35545387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Nordic Multimorbidity Index Based on Hospital Diagnoses and Filled Prescriptions.
    Kristensen KB; Lund LC; Jensen PB; Broe A; Rotbain E; Damkier P; Pottegård A; Andersen JH; Højlund M; Olesen M; Rasmussen L; Hansen MR; Ernst MT; Wesselhoeft R; Henriksen DP; Reilev M; Bliddal M; Hallas J
    Clin Epidemiol; 2022; 14():567-579. PubMed ID: 35509520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of an extensive medication-based comorbidity index (Rx-Risk) in explaining the excess mortality after hip fracture in older Norwegians: a NOREPOS cohort study.
    Holvik K; Hjellvik V; Karlstad Ø; Gunnes N; Hoff M; Tell GS; Meyer HE
    BMJ Open; 2022 May; 12(5):e057823. PubMed ID: 35501100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimorbidity patterns among rural adults with Type-2 diabetes mellitus: A cross-sectional study in Kerala, India.
    Soji DJ; Lordson J; Mini GK
    WHO South East Asia J Public Health; 2021; 10(1):32-36. PubMed ID: 35046156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimorbidity and achievement of treatment goals among patients with type 2 diabetes: a primary care, real-world study.
    Heikkala E; Mikkola I; Jokelainen J; Timonen M; Hagnäs M
    BMC Health Serv Res; 2021 Sep; 21(1):964. PubMed ID: 34521389
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.